Clinical trial
Safety and Efficacy of NeuroFlo in 8-24 Hour Stroke Patients
NCT00436592 · CoAxia, Industry · Completed
Key facts
| NCT number | NCT00436592 |
|---|---|
| Title | Safety and Efficacy of NeuroFlo in 8-24 Hour Stroke Patients |
| Official title | Safety and Efficacy of NeuroFlo in 8-24 Hour Stroke Patients |
| Acronym | Flo 24 |
| Lead sponsor | CoAxia, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cerebrovascular Accident |
| Intervention type | Device |
| Interventions | NeuroFlo™ Catheter |
| Enrollment | 26 |
| Start date | Feb 1, 2007 |
| Primary completion | Jan 1, 2009 |
| Completion | Jan 1, 2009 |
| First posted | Feb 19, 2007 |
| Last update posted | Feb 5, 2009 |
| Countries | Canada, Germany, Switzerland, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: